Clinical Trial Update: Riluzole in Huntington's Disease [Phase 3]

View source ↗

Summary

Sanofi-sponsored Phase 3 trial of riluzole for Huntington's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Sanofi | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED